Aetna will now reimburse for iRhythm's ZIO Patch, a continuous long-term heart monitor worn on an adhesive patch. The insurer recently updated its Clinical Policy Bulletin on cardiac event monitors, ...

iRhythm Technologies, maker of the Zio patch peel-and-stick heart monitor, has raised $17 million in a round led by Novo A/S, a Danish life sciences investment firm. Previous investor Norwest Venture ...

Wearables maker iRhythm Technologies on Tuesday released data suggesting its Zio patch increased rate of atrial fibrillation detection and reduced cardiac events, in results presented at the American ...

iRhythm Technologies today unveiled initial findings on the post-market and real-world performance of its Zio monitor, building on the devices previous generation of the long-term continuous ...

SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio® monitor, its ...

iRhythm Technologies’ wearable cardiac monitor is evolving with the help of two new FDA clearances. The San Francisco, CA-based company’s Zio Patch is now boasting an improved design and updated ...

iRhythm Technologies, Inc. is a key player in the US ambulatory cardiac monitoring market for arrhythmias. The company's Zio monitors utilize advanced AI and machine learning algorithms for the ...

SAN FRANCISCO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced the U.S. launch of its next-generation Zio® monitor and enhanced Zio® long-term continuous ...

SAN DIEGO – Research by the Scripps Translational Science Institute (STSI) has found that a small adhesive wireless device worn on the chest for up to two weeks does a better job detecting abnormal ...

A new prospective study finds that the use of iRhythm's (San Francisco) ZIO Service significantly increased detection of cardiac arrhythmias, compared to the use of the traditional Holter monitor. The ...